Authors: MIYAWAKI S TANIMOTO M KOBAYASHI T MINAMI S TAMURA J HATAKE K KURIYAMA K OHMOTO E SAITO K KANAMARU A OHO H OHTAKE S JINNAI I SAKAMAKI H YAMADA O ASOU N TAKAHASHI M TAKEYAMA K MATSUDA S UEDA R OHNO R

Citation: S. Miyawaki et al., RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT ETOPOSIDE IN ADULT ACUTE MYELOID-LEUKEMIA (EXCEPT FOR M3) (JALSG-AML92STUDY) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 90(10), 1997, pp. 2244-2244

Authors: KOBAYASHI T MIYAWAKI S TANIMOTO M KURIYAMA K MURAKAMI H YOSHIDA M MINAMI S MINATO K TSUBAKI K OHMOTO E OH H JINNAI I SAKAMAKI H HIRAOKA A KANAMARU A TAKAHASHI I SAITO K NAOE T YAMADA O ASOU N KAGEYAMA S EMI N MATSUOKA A TOMONAGA M SAITO H UEDA R OHNO R

Citation: T. Kobayashi et al., RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 14(1), 1996, pp. 204-213

Authors: OHNO R ASOU N KANAMARU A ADACHI K MIYAWAKI S KAGEYAMA S HIRAOKA A OHMOTO E SAKAMAKI H TSUBAKI K SAITO K KURIYAMA K OH H KITANO Y

Citation: R. Ohno et al., JALSG-AML92 FOR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CONSOLIDATION ACID MAINTENANCE INTENSIFICATION CHEMOTHERAPY - PROGNOSTIC FACTORS FORREMISSION AND SURVIVAL/, Blood, 88(10), 1996, pp. 1157-1157

Authors: KANAMARU A TAKEMOTO Y TANIMOTO M MURAKAMI H ASOU N KOBAYASHI T KURIYAMA K OHMOTO E SAKAMAKI H TSUBAKI K HIRAOKA A YAMADA O OH H SAITO K MATSUDA S MINATO K UEDA T OHNO R

Citation: A. Kanamaru et al., ALL-TRANS-RETINOIC ACID FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 85(5), 1995, pp. 1202-1206

Authors: OHNO R OHNISHI K TAKESHITA A TANIMOTO M MURAKAMI H KANAMARU A ASOU N KOBAYASHI T KURIYAMA K OHMOTO E SAKAMAKI H TSUBAKI K HIRAOKA A YAMADA O OH H FURUSAWA S MATSUDA S NAOE T

Citation: R. Ohno et al., ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN, Leukemia, 8, 1994, pp. 64-69

Authors: KOBAYASHI T MIYAWAKI S TANIMOTO M KURIYAMA K MURAKAMI H YOSHIDA M KODERA Y MINATO K TSUBAKI K OHMOTO E OH H JINNAI I SAKAMAKI H HIRAOKA A KANAMARU A TAKAHASHI I FURUSAWA S NAOE T YAMADA O ASOU N NISHIKAWA K OKABE K OGURA M TANAKA M OHNO R

Citation: T. Kobayashi et al., RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000146-10000146